Jiudian Pharmaceutical announced that it has recently received the “Drug Clinical Trial Approval Notice” issued by the State Drug Administration for ifluprofen patches. Clinical trial research will be carried out after completing relevant preparations.
九典制药：获得艾氟洛芬贴剂药物临床试验批准通知书
Jiudian Pharmaceutical: Obtaining a Notice of Approval for Clinical Trials of Effluprofen Patches
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.